# US 2010/0166893 A1 · Herbal composition for reducing add/adhd and method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166893 A1
- Document ID: US20100166893A1
- Status: Published application
- Kind: A1
- Application number: 12/663,406
- Filed: 2009-04-17
- Published: 2010-07-01
- Earliest claimed: 2008-04-19
- Assignees: Nisarga Biotech PVT. Ltd.
- Inventors: Girish Sudhakar Soman; Shrikrishna Govind Phadke
- Web page: https://patentgrep.com/patent/US20100166893A1

## CPC

- A61K 36/53: Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K 36/55: Linaceae (Flax family), e.g. Linum
- A61K 36/80: Scrophulariaceae (Figwort family)
- A61K 36/9068: Zingiber, e.g. garden ginger
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 25/16: Anti-Parkinson drugs
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Disclosed herein is a herbal composition comprising supercritical fluid extracts/oils of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E in an effective amounts useful in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).

## Claims

### Claim 1

A herbal composition comprising:
a supercritical fluid extract or oil of Jyotishmati;
a supercritical fluid extract or oil of Bacopa monnieri;
a supercritical fluid extract or oil of Ginger Oil;
a supercritical fluid extract or oil of Flax Seed oil;
a supercritical fluid extract or oil of Rosemary Ext; and
Vitamin E;
said supercritical fluid extracts or oils being present in an effective amount useful in the treatment of symptoms associated with Attention Deficit disorder (ADD) or Attention deficit/hyperactivity disorder (ADHD).

### Claim 2 (depends on 1)

The herbal composition as claimed in claim 1, wherein said composition comprises Jyotishmati oil (Celestris paniculata seed oil) in an amount of about 5 to 50% of the total formulation; Flax seed oil (Linum usiatissium seeds) in an amount of about 30 to 65%; Bacopa monniera extract in an amount of from greater than 0% to about 10%; Rosmarinus officinalis extract from greater than 0% to about 10%, Ginger (Zingiber officinalis) extract in an amount of from greater than 0% to about 4% and natural Vitamin E (α Tocopherols) in an amount of from greater than 0% to about 2%.

### Claim 3 (depends on 1)

The herbal composition as claimed in claim 1, wherein said composition optionally comprises sesame oil.

### Claim 4 (depends on 1)

The herbal composition as claimed in claim 1, wherein said composition in higher dose comprises Jyotishmati oil CO2 in the range of 32-38%; Bacopa monnieri extract CO2 in the range of from 4-7%; Ginger oil (T) CO2 in the range of from 0.5 to 1.5%; Flax seed oil CO2 in the range of about 51-58%; Rosemary extract CO2 in the range of 3 to 6% and Vitamin E in the range of 0.3 to 0.6%.

### Claim 5 (depends on 4)

The herbal composition as claimed in claim 4, wherein said composition comprises Jyotishmati oil CO2 35%; Bacopa monnieri extract CO2 5%; Ginger oil (T) CO2 1%; Flax seed oil CO2 54.6%; Rosemary extract CO2 4% and vitamin E 0.4%.

### Claim 6 (depends on 3)

The herbal composition as claimed in claim 3, wherein said composition in lower dose comprises from 20-26% Jyotishmati oil CO2; from 2-6% Bacopa monnieri extract CO2; from 0.5-0.8% Ginger oil (T) CO2; Flax seed oil CO2 in the range of 32-40%; Rosemary extract CO2 in the range of 2-5%; Vitamin E in the range of 0.17% to 0.30% and Sesame oil in the range of 30-35%.

### Claim 7 (depends on 6)

The herbal composition as claimed in claim 6, wherein said composition comprises 23.33% Jyotishmati oil CO2; 3.33% Bacopa monnieri extract CO2; 0.67% Ginger oil (T) CO2; 36.4% Flax seed oil CO2; 2.66% Rosemary extract CO2; 0.27% vitamin E and 33.33% Sesame oil.

### Claim 8 (depends on 1)

The herbal composition as claimed in claim 1, wherein said composition optionally comprises a pharmaceutical excipient.

### Claim 9 (depends on 8)

The herbal composition as claimed in claim 8, wherein said pharmaceutical excipients is selected from the group consisting of binders, diluents, lubricants, disintegrants, pharmaceutical oils and bases.

### Claim 10

A process for preparation of a composition comprising supercritical extracts and oils of active ingredients of Celastrus paniculatus, Linum usitatissimum, Bacopa monnieri, Zingiber officinalis and Rosemary comprising the following steps:
a) shade drying fresh and dust free herbal parts of Celastrus paniculatus, Linum usitatissimum, Bacopa monnieri. Zingiber officinalis and Rosemary required for extraction;
b) grinding of said fresh and dust free herbal parts to make a fine powder after drying;
c) transferring said fine powder into an extraction chamber;
d) passing high pressure CO2 through said extraction chamber for a predetermined time and at predetermined temperature to produce CO2 extracts or oils;
e) removing the CO2 extracts or oils through a separator; and
f) optionally formulating the CO2 extracts or oils into a herbal composition.

### Claim 11 (depends on 1)

A method of treating a patient exhibiting symptoms associated with attention Deficit Disorder (ADD) and Attention Deficit/Hyperactivity Disorder (ADHD) comprising administering a composition according to claim 1 to said patient.

### Claim 12 (depends on 1)

A method for treating symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD), which method comprises administering an effective amount of the composition of claim 1 to the subject suffering symptoms associated with attention Deficit Disorder (ADD) and Attention Deficit/Hyperactivity Disorder (ADHD) for a period of up to 3 to 12 months.

### Claim 13 (depends on 12)

The method as claimed in claim 12, wherein said subject is human.

### Claim 14 (depends on 12)

The method according to claim 12, wherein said associated symptoms are selected from Learning disabilities, Tourette Syndrome, Oppositional defiant disorder, Conduct disorder, Bipolar disorder, Dymensia, Parkinson, Alzheimer and Hypertensive Disorder/High Blood Pressure, loss of memory, Austin, OCI PDD-NOS, RETTS, Aspergers, epilepsy, Dyspraxia, Dyslexia, Cerebellar, Ataxia, Down Syndrome, Schizophrenia and other neurodevelopmental disorders that result in leaning and behavioral issues.

### Claim 15

A method of enhancing memory in a patient, comprising the step of administering a herbal composition comprising supercritical fluid extract or oil of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E to said patient.

### Claim 16

A method of reducing oxidative stress in a patient, comprising the step of administering a herbal composition comprising supercritical fluid extract or oil of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E to said patient.

### Claim 17

A herbal composition comprising a supercritical fluid extract or oil of Jyotishmati and a supercritical fluid extract or oil of Flax Seed oil, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E in an amount effective to produce a reduction in ADHD Score and a clinically meaningful reduction in ADHD symptoms.

### Claim 18

A method of improving scholastic performance or intelligence quotient of a student comprising the step of administering a herbal composition comprising supercritical fluid extract or oil of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext and Vitamin E to said student.

### Claim 19

A herbal composition comprising a) at least two supercritical fluid extracts or oils, each of said supercritical fluid extract or oil being selected from the group consisting of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary Ext, and mixtures thereof; and optionally b) Vitamin E;
said supercritical fluid extract or oil being present in an effective amount useful in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).

### Claim 20 (depends on 4)

A method of treating a patient exhibiting symptoms associated with attention Deficit Disorder (ADD) and Attention Deficit/Hyperactivity Disorder (ADHD) comprising administering a composition according to claim 4 to said patient.

### Claim 21 (depends on 6)

A method of treating a patient exhibiting symptoms associated with attention Deficit Disorder (ADD) and Attention Deficit/Hyperactivity Disorder (ADHD) comprising administering a composition according to claim 6 to said patient.

### Claim 22

A herbal composition comprising: supercritical fluid extract or oil of Jyotishmati, Bacopa monnieri, Ginger Oil, Flax Seed oil, Rosemary extract and Vitamin E in an effective amount useful in the treatment of symptoms associated with Attention Deficit disorder (ADD) and Attention deficit/hyperactivity disorder (ADHD).

### Claim 23 (depends on 19)

The herbal composition as claimed in claim 19, wherein said at least two supercritical fluid extracts or oils include at least extracts or oils of Jyotishmati and Flax Seed oil.

### Claim 24 (depends on 19)

A method of treating a patient exhibiting symptoms associated with attention Deficit Disorder (ADD) or Attention Deficit/Hyperactivity Disorder (ADHD) comprising administering a composition according to claim 19 to said patient.
